【Indian Pharma Post】Amaran Biotech Signs MOU with Nippon Fine Chemical for Nanoparticle Drug CDMO Expansion

【Pharma Source】Amaran Biotech Signs MOU with Nippon Fine Chemical for Nanoparticle Drug CDMO Expansion

【Contract Pharma】Amaran Biotech, Nippon Fine Chemical Sign MOU

【Yahoo!Finance】Amaran Biotech Signs MOU with Nippon Fine Chemical

【Macau Business】Amaran Biotech Signs MOU with Nippon Fine Chemical

【Medindia】Amaran Biotech Signs MOU with Nippon Fine Chemical

Amaran Biotech Signs MOU with Nippon Fine Chemical Joining Forces with Zillion Fine Chemicals to Expand CDMO Business

Amaran Biotechnology Inc., a subsidiary of OBI Pharma specializing in Contract Development and Manufacturing Organization (CDMO) services for next-generation pharmaceuticals, announced today that it has signed a Memorandum of Understanding (MOU) with Nippon Fine Chemical Co., Ltd., and its Taiwan subsidiary, Zillion Fine Chemicals International Co., Ltd. The three parties aim to deepen collaboration in the field of nanoparticle-based drug CDMO manufacturing while expanding their presence in Taiwan, Japan, and international CDMO markets.

【Outsourced Pharma】Amaran Biotech Signs MOU With Nippon Fine Chemical

Amaran Biotech Advances with Warehouse Management System

Amaran Biotech, through the close collaboration of its IT, Warehouse, and Quality Management (QM) departments, has successfully implemented a Warehouse Management System (WMS) developed by Unitech Electronics. This system enables fully digitized management for the warehouse operation and the DS and DP production lines of Amaran. As the core of manufacturing and supply chain operations, the WMS oversees the entire material management process—from raw materials to finished products—aiming to optimize product and material handling with high efficiency and low cost.

Advancing mRNA Therapeutics with Lipid Nanoparticles

Lipid nanoparticles (LNPs) have revolutionized the delivery of mRNA therapeutics, providing stability, targeted delivery, and protection against degradation. From COVID-19 vaccines to cancer immunotherapies and genome editing, these systems represent a transformative shift in medicine.

QS-21: A Promising Saponin Adjuvant for Enhancing Vaccine Efficacy

QS-21, a saponin-derived adjuvant extracted from the bark of the Quillaja saponaria tree, has emerged as a key player in the field of vaccine development. Recognized for its ability to enhance immune responses, QS-21 is increasingly being explored as a vital component in vaccine formulations aimed at improving immunogenicity and overall effectiveness.

The Importance of Quality Control to Aseptic Filling

Based on PIC/S Annex 1 “Manufacture of Sterile Medicinal Products”, it is particularly important to ensure the quality and safety of sterile medicinal products throughout their manufacturing process. QC has played an essential role in the control and reduction of contamination by microorganisms, particulates and endotoxins/pyrogens.